Form 4: Chemours Director Alister Cowan Acquires 10,200 Shares in Open Market Transaction

Chemours director Alister Cowan purchased 10,200 shares of company stock at a weighted average price of $19.2619 per share.

Summary

• Alister Cowan, a director at Chemours Co, acquired 10,200 shares of common stock on November 15, 2024.
• The shares were purchased at a weighted average price of $19.2619 per share.
• The transactions occurred in multiple trades with prices ranging from $19.16 to $19.30 per share.
• Following the transaction, Cowan's total holdings increased to 21,582.761 shares, which includes directly owned shares, stock units, and dividend equivalent units.

Sentiment

Score: 6

Explanation: The document is a routine filing and does not indicate any significant positive or negative sentiment. The purchase by a director is a mild positive.

Positives

• The purchase of shares by a director can be seen as a positive sign of confidence in the company's future.

Industry Context

This is a routine filing related to insider trading activity and is common for publicly traded companies. It does not indicate any specific trend in the chemical industry.

Comparison to Industry Standards

• Form 4 filings are standard practice for all publicly traded companies in the US.
• The transaction is not unusual in terms of size or price for a director's purchase of company stock.
• Similar filings are made by directors and officers of companies like Dow, DuPont, and BASF when they trade their company's stock.

Stakeholder Impact

• The purchase may have a slightly positive impact on shareholder sentiment.

Key Dates

Keywords

Chemours, Director, Insider Trading, Stock Purchase, Form 4, Alister Cowan, Share Acquisition